Picture of BioPorto A/S logo

BIOPOR BioPorto A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Bioporto Sees FY 2023 Revenue Between Approximately DKK 30 Mln To 33 Mln

March 29 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * BIOPORTO ANNOUNCES FINANCIAL GUIDANCE FOR 2023
    * SEES FY23 REVENUE BETWEEN APPROXIMATELY DKK 30 MILLION TO
33
MILLION
    * WHILE FDA APPROVAL IS PENDING, COSTS RELATED TO FUTURE
CLINICAL
STUDIES ARE ASSUMED TO BE LOWER THAN IN 2022
    * SEES 2023 ADJUSTED EBITDA LOSS OF APPROXIMATELY DKK 60
MILLION
TO DKK 65 MILLION

Source text for Eikon:  ID:nGNE2hqmSf 
Further company coverage:  BIOPOR.CO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BioPorto A/S

See all news